Today at #ASCO24, research partner Washington University School of Medicine in St. Louis will lead an oral presentation highlighting a study demonstrating the use of liquid biopsy in addressing racial inequities in the use of targeted therapies and enrollment in clinical trials for advanced breast cancer. The study, part of an ongoing collaboration with Precision Medicine Academic Consortium, is aimed at advancing the use of liquid biopsy in patients with metastatic breast cancer.
Congratulations Leslie Bucheit, Drs Podany & Davis and the Wash U Breast Cancer team.
Oncology Hospital Healthcare Sales
4moCongratulations. That's a major advancement in breast cancer.